Rankings
▼
Calendar
RYTM Q4 2016 Earnings — Rhythm Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
RYTM
Rhythm Pharmaceuticals, Inc.
$6B
Q4 2016 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$8M
Net Income
-$8M
EPS (Diluted)
$-0.50
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$6M
Free Cash Flow
-$6M
Stock-Based Comp.
$309,000
Balance Sheet
Total Assets
$12M
Total Liabilities
$5M
Stockholders' Equity
$7M
Cash & Equivalents
$7M
← FY 2016
All Quarters
Q1 2017 →
